andrewlinscott / iStockphoto.com
16 August 2019Big PharmaSaman Javed
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
Several pharma bodies have signed non-disclosure agreements (NDAs) which prevent them from disclosing the UK government’s plans for a no-deal Brexit.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Europe
8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.
Big Pharma
21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.
Big Pharma
3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.
Editor's picks
Editor's picks
Europe
8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.
Big Pharma
21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.
Big Pharma
3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.
Europe
8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.
Big Pharma
21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.
Big Pharma
3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.